11 May 2021>: Original Paper
Surgical Outcome of Pulmonary Metastasectomy for Hepatocellular Carcinoma Recurrence in Liver Transplant Patients
Yong Ho Jeong 1ABCDEFG , Shin Hwang 2ACDEF , Geun Dong Lee 1AB , Se Hoon Choi 1AB , Hyeong Ryul Kim 1AB , Yong-Hee Kim 1AB , Seung-Il Park 1AB , Dong Kwan Kim 1ABCDEFG*DOI: 10.12659/AOT.930383
Ann Transplant 2021; 26:e930383
Table 1 Clinicopathological characteristics of the 52 patients who underwent pulmonary metastasectomy for lung metastases after liver transplantation for hepatocellular carcinoma.
Parameter | Value |
---|---|
Age, mean±SD (range), year | 56.0±6.6 (~37–69) |
Male/Female | 46 (88.5%)/6 (11.5%) |
Living-donor LT | 41 (78.8%) |
Deceased-donor LT | 11 (21.2%) |
1.88±2.18 (0.90, ~0.04–8.48) | |
~0–1 yr | 28 (53.8%) |
>~1–2 yrs | 7 (13.5%) |
>2 yrs | 17 (32.7%) |
~1–10 | 21 (40.4%) |
>~10–20 | 25 (48.1%) |
>20 | 6 (11.5%) (up to 35 mm) |
Single | 34 (65.4%) |
Multiple (range, median) | 18 (34.6%) (~2–7, 3) |
Wedge resection | 50 (96.2%) |
Open | 4 (7.7%) |
VATS | 46 (88.5%) |
Lobectomy | 2 (3.8%) |
Open | 1 (1.9%) |
VATS | 1 (1.9%) |
Normal (0–10 ng/mL) | 34 (65.4%) |
Elevated (>10 ng/mL) | 18 (34.6%) |
3 (~2–22) | |
Postoperative complication | |
Persistent air leak (>7 days) | 4 (7.7%) |
Yes | 33 (63.5%) |
No | 19 (36.5%) |
AFP – alpha-fetoprotein; LT – liver transplantation; PM – pulmonary metastasis; VATS – video-assisted thoracoscopic surgery. Results reported as n (%), unless otherwise indicated. |